Morgan Stanley’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | -$3 | – | 7692 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7690 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7874 |
|
|
2022
Q3 | – | Sell |
-316
| Closed | -$70.5K | – | 7833 |
|
|
2022
Q2 | $64K | Sell |
316
-10
| -3% | -$2.5K | ﹤0.01% | 6500 |
|
|
2022
Q1 | $123K | Buy |
326
+316
| +3,160% | +$120K | ﹤0.01% | 6188 |
|
|
2021
Q4 | $4K | Buy |
+10
| New | +$5.76K | ﹤0.01% | 7694 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8003 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7787 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7542 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7095 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6808 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6697 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6676 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6739 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6726 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6718 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6528 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6700 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6777 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6726 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6552 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6500 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6461 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6461 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6386 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6307 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6439 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6368 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6481 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6511 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6419 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5745 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6006 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5767 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6080 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4934 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 4720 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4607 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4550 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 4497 |
|
Other funds holding PSTV
TRCT
Morgan Stanley's PSTV Position: Q2 2023 in Review
Morgan Stanley held its Plus Therapeutics (PSTV) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7692.
Morgan Stanley first reported a position in PSTV in Q4 2021 and has held it in 3 quarters since. The position peaked at $123K in Q1 2022. 6 funds tracked by Wall St. Rank hold PSTV as of Q2 2023.
- Morgan Stanley held 0 shares of Plus Therapeutics worth $0 as of Q2 2023.
- Morgan Stanley left its Plus Therapeutics share count unchanged in Q2 2023.
- Plus Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2023, its #7692 holding.
- Morgan Stanley first reported a position in Plus Therapeutics in Q4 2021 and has held it in 3 quarters since.
- Morgan Stanley's Plus Therapeutics position peaked at $123K in Q1 2022.
- 6 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2023.
Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.